Back to Search
MARC RABINOWITZ, MD
MD
Internal Medicine Physician
NPI: 1922111210IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
MD039949E(PA)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
TEMPLE UNIVERSITY SCHOOL OF MEDICINE
Class of 1986
Research & Publications (19)
Progression to severe retinopathy predicted by retinal vessel diameter between 31 and 34 weeks of postconception age.
PMID 17998510·Arch Ophthalmol·2007
8-other
Accurate prediction of HIV-1 drug response from the reverse transcriptase and protease amino acid sequences using sparse models created by convex optimization.
PMID 16368772·Bioinformatics·2006
8-other
Lead isotopes in soils near five historic American lead smelters and refineries.
PMID 15993689·Sci Total Environ·2005
8-other
Design of selective and soluble inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).
PMID 11708926·J Med Chem·2001
7-preclinical
Solid-phase/solution-phase combinatorial synthesis of neuroimmunophilin ligands.
PMID 10843203·Bioorg Med Chem Lett·2000
8-other
Characterization of a robust enzymatic assay for inhibitors of 2-oxoglutarate-dependent hydroxylases.
PMID 19498081·J Biomol Screen·2009
8-other
Discovery of potent cholecystokinin-2 receptor antagonists: elucidation of key pharmacophore elements by X-ray crystallographic and NMR conformational analysis.
PMID 18289861·Bioorg Med Chem·2008
7-preclinical
Synthesis and solid-phase purification of anthranilic sulfonamides as CCK-2 ligands.
PMID 18029172·Bioorg Med Chem Lett·2007
7-preclinical
Identification and optimization of anthranilic sulfonamides as novel, selective cholecystokinin-2 receptor antagonists.
PMID 17034143·J Med Chem·2006
7-preclinical
Substrate specificity and novel selective inhibitors of TNF-alpha converting enzyme (TACE) from two-dimensional substrate mapping.
PMID 16101009·Comb Chem High Throughput Screen·2005
8-other
Hantzsch synthesis of pyrazolo[1',2':1,2]pyrazolo[3,4-b]pyridines: partial agonists of the calcitonin receptor.
PMID 15960543·J Org Chem·2005
8-other
Isotopic characterization of six major brands of white basic lead carbonate paint pigments.
PMID 12375107·Bull Environ Contam Toxicol·2002
8-other
Isotopic characterization of various brands of corroding grade refined lead metal.
PMID 12232720·Bull Environ Contam Toxicol·2002
8-other
Investigation of unrecognized former secondary lead smelting sites: confirmation by historical sources and elemental ratios in soil.
PMID 11916041·Environ Pollut·2002
8-other
N-hydroxyformamide peptidomimetics as TACE/matrix metalloprotease inhibitors: oral activity via P1' isobutyl substitution.
PMID 11514157·Bioorg Med Chem Lett·2001
7-preclinical
Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases.
PMID 11504783·J Pharmacol Exp Ther·2001
7-preclinical
Discovering unrecognized lead-smelting sites by historical methods.
PMID 11291377·Am J Public Health·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 965 STREET RD
SOUTHAMPTON, PA 18966 - Phone
- (215) 357-2666
Quick Facts
- NPI
- 1922111210
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 40
- Publications
- 19
Are you this provider?
Claim Your Profile